Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells von Markovska, A., Somers, K., Guillaume, J., Melief, J., Mazar, A. P., Schmitt, D. M., Schipper, H. S., Boes, M.

Volltext

PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe von Severin, G. W., Fonslet, J., Kristensen, L. K., Nielsen, C. H., Jensen, A. I., Kjær, A., Mazar, A. P., Johnston, K., Köster, U.

Volltext

Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer von Boonstra, M.C, Van Driel, P.B.A.A, Keereweer, S, Prevoo, H.A.J.M, Stammes, M.A, Baart, V.M, Löwik, C.W.G.M, Mazar, A.P, van de Velde, C.J.H, Vahrmeijer, A.L, Sier, C.F.M

Volltext

9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers von Kuroki, H., Anraku, T., Bilim, V., Tasaki, M., Schmitt, D., Mazar, A., Ugolkov, A., Tomita, Y.

Volltext

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours von Cianfrocca, M E, Kimmel, K A, Gallo, J, Cardoso, T, Brown, M M, Hudes, G, Lewis, N, Weiner, L, Lam, G N, Brown, S C, Shaw, D E, Mazar, A P, Cohen, R B

Volltext

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224) von Doñate, F, Juarez, J C, Burnett, M E, Manuia, M M, Guan, X, Shaw, D E, Smith, E L P, Timucin, C, Braunstein, M J, Batuman, O A, Mazar, A P

Volltext

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer von Mazar, Andrew P

Volltext

GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA von Karmali, R., Chukkapalli, V., Pro, B., Borgia, J.A., Mazar, A., Ugolkov, A., Giles, F.J.

Volltext

Experimental studies on ethanol solubility and nanoparticle (NP) stability in diesel fuel von Shaikh, Mazar A., Patel, Vimal R.

Volltext

Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction von Tarui, Takehiko, Mazar, Andrew P., Cines, Douglas B., Takada, Yoshikazu

Volltext

The urokinase plasminogen activator system in cancer : Implications for tumor angiogenesis and metastasis von MAZAR, A. P, HENKIN, J, GOLDFARB, R. H

Volltext

Development of novel thermal storage integrated pasteurizer for solar milk pasteurization system von Dabhi, Shyam K., Patel, Vimal R., Shaikh, Mazar A., Parmar, Dipakkumar J.

Volltext

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor von Colman, R W, Pixley, R A, Najamunnisa, S, Yan, W, Wang, J, Mazar, A, McCrae, K R

Volltext

Optimizing CI Engine Ethanol Fuel Induction Techniques Using the AHP-PROMETHEE II Hybrid Decision Model von Shaikh, Mazar A, R Patel, Vimal

Volltext

Structural requirements for the growth factor activity of the amino-terminal domain of urokinase von RABBANI, S. A, MAZAR, A. P, BERNIER, S. M, HAQ, M, BOLIVAR, I, HENKIN, J, GOLTZMAN, D

Volltext

Selective inhibition of metastasis in vivo, partly through disruption of nucleoli von Frankowski, K. J., Wang, C., Patnaik, S., Schoenen, F. J., Southall, N., Li, D., Teper, Y., Sun, W., Kandela, I., Hu, D., Dextras, C., Knotts, Z., Bian, Y., Norton, J., Titus, S., Lewandowska, M. A., Wen, Y., Farley, K. I., Griner, L. M., Sultan, J., Meng, Z., Zhou, M., Vilimas, T., Powers, A. S., Kozlov, S., Nagashima, K., Quadri, H. S., Fang, M., Long, C., Khanolkar, O., Chen, W., Kang, J., Huang, H., Chow, E., Goldberg, E., Feldman, C., Xi, R., Kim, H. R., Sahagian, G., Baserga, S. J., Mazar, A., Ferrer, M., Zheng, W., Shilatifard, A., Aubé, J., Rudloff, U., Marugan, J. J., Huang, S.

Volltext

Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA) von Rabbani, Shafaat, Harakidas, Penelope, Davidson, Donald J., Henkin, Jack, Mazar, Andrew P.

Volltext

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells von Markovska, A, Somers, K, Guillaume, J, Melief, J, Mazar, A P, Schmitt, D M, Schipper, H S, Boes, M

Volltext

Fraternities and Campus Sexual Violence: Risk, Protection, and Prevention von Mazar, Laurel A., Kirkner, Anne

Volltext

A Peptide Derived from the Non-Receptor-Binding Region of Urokinase Plasminogen Activator Inhibits Glioblastoma Growth and Angiogenesis in vivo in Combination with Cisplatin von Mishima, Kazuhiko, Mazar, Andrew P., Gown, Allen, Skelly, Marilyn, Ji, Xiang-Dong, Wang, Xu-Dong, Jones, Terence R., Cavenee, Webster K., H.-J. Su Huang

Volltext